Skip to content

Allogran-R

by Biocomposites Ltd

510(k) K061311

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK061311 Date22 Sep 2006ClearedStatusActive

Official records

From the FDA record

Received by the FDA
10 May 2006
FDA decision
22 Sep 2006 (Substantially Equivalent)
FDA review time
135 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K061311 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MQV
FDA applicant
Biocomposites, Ltd.
Device class
Class II
Regulation
21 CFR Part 888.3045
Advisory committee
Orthopedic
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Allogran-R is a synthetic bone graft substitute composed of polycrystalline, porous tri-calcium phosphate granules and blocks. It is designed to support bone regeneration in trauma and spinal procedures by providing a scaffold for new bone formation.

The device is supplied sterile for single-patient use and is radiopaque, allowing for radiographic visualization. Manufactured from medical-grade tri-calcium phosphate, Allogran-R is biodegradable with resorption occurring over approximately 6–12 months when used as intended. It holds an FDA 510(k) clearance under the product code MQV and advisory committee classification OR.

Devices cleared under K061311

5 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K061311
UDI-DISize and differences
Allogran-R® 800-005
BIOCOMPOSITES LTD
800-005 / 800-00550601557100202 —No longer on the market
Allogran-R® 800-005
BIOCOMPOSITES LTD
800-005 / 800-00515060155710027 —On the market
Allogran-R® 800-010
BIOCOMPOSITES LTD
800-010 / 800-01015060155710034 —On the market
Allogran-R® 800-010
BIOCOMPOSITES LTD
800-010 / 800-01050601557100370 —No longer on the market
Allogran-R® 800-020
BIOCOMPOSITES LTD
800-020 / 800-02050601557100448 —No longer on the market

Similar devices

Other devices filed under FDA product code MQV (Filler, Bone Void, Calcium Compound).

Other devices from Biocomposites Ltd

See all devices from Biocomposites Ltd →